Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

The global scourge of counterfeit medicines

8 November 2016

The statistics are truly disturbing, with an annual death toll […]

Commission to Look into ‘Skyrocketing’ EU Drug Prices, Availability, and Patient Access

20 June 2016

Medicines for Europe: Better Access, Better Health

1 March 2016

EGA Prioritises Pursuing Sustainability Agreements

12 February 2016

Para Permitirse los Fármacos Innovadores Hay que Apoyar los Genéricos

22 November 2015

EFG: la EGA Califica de “Mala Noticia” la Eliminación de la Discriminación Positiva

17 November 2015